Cash flow used in investing activities was €42 million, an increase of €15 million from €27 million in the same period last year.
Related party transactions
For related party transactions please refer to note 10 of our interim financial report.
Principal risks and uncertainties H1 2010
A detailed discussion of the Group’s principal risks and uncertainties can be found in the Annual Report 2010.
In the 2010 Annual Report we extensively described certain risk categories and risk factors which could have a material adverse effect on our financial position and results.
Those risk categories and risk factors are deemed incorporated and repeated in this report by reference.
Other risks not known to us, or currently believed not to be material, could later turn out to have a negative material impact on our business, objectives, revenues, income, assets, liquidity or capital resources.
Responsibility statement
The Board of Management hereby declares that, to the best of their knowledge:
- the interim financial statements prepared in accordance with IAS 34, “Interim Financial Reporting”, give a true and fair view of the assets, liabilities, financial position, profit and loss of the company and the undertakings included in the consolidation taken as a whole; and
- the interim report of the Management Board gives a fair review of the information required pursuant to section 5:25d(8)/(9) of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht).
| Harold Goddijn, CEO |
| Marina Wyatt, CFO |
| Alain De Taeye |
22 July 2011
Consolidated statement of income
| (in € thousands) | Q2 ’11 | Q2 ’10 | H1 '11 | H1 '10 | ||||
| Revenue | 314,224 | 361,974 | 579,371 | 630,330 | ||||
| Cost of sales | 154,269 | 177,077 | 278,494 | 301,182 | ||||
| Gross result | 159,955 | 184,897 | 300,877 | 329,148 | ||||
| Research and development expenses | 40,776 | 40,304 | 82,505 | 81,268 | ||||
| Amortisation of technology & databases | 19,204 | 19,134 | 37,824 | 36,547 | ||||
| Marketing expenses | 30,148 | 24,108 | 40,396 | 39,232 | ||||
| Selling, general and administrative expenses | 49,844 | 48,466 | 99,163 | 99,454 | ||||
| Impairment charge | 511,936 | 0 | 511,936 | 0 | ||||
| Stock compensation expense | 2,025 | 3,244 | 4,872 | 6,005 | ||||
| Total operating expenses | 653,933 | 135,256 | 776,696 | 262,506 | ||||
| Operating result | -493,978 | 49,641 | -475,819 | 66,642 | ||||
| Interest result | -6,050 | -8,967 | -12,094 | -17,455 | ||||
| Other finance result | 2,185 | 4,872 | 3,850 | -783 | ||||
| Result associates | 60 | -2,395 | -272 | -1,466 | ||||
| Result before tax | -497,783 | 43,151 | -484,335 | 46,938 | ||||
| Income tax | 8,443 | -9,685 | 5,466 | -10,543 | ||||
| Net result | -489,340 | 33,466 | -478,869 | 36,395 | ||||
| Net result attributable to: | ||||||||
| Equity holders of the parent | -489,247 | 33,716 | -478,667 | 36,801 | ||||
| Non-controlling interests | -93 | -250 | -202 | -406 | ||||
| -489,340 | 33,466 | -478,869 | 36,395 | |||||
| Basic number of shares (in thousands) | 221,888 | 221,718 | 221,861 | 221,718 | ||||
| Diluted number of shares (in thousands) | 222,168 | 221,830 | 223,328 | 221,940 | ||||
| EPS, € basic | -2.20 | 0.15 | -2.16 | 0.17 | ||||
| EPS, € diluted¹ | -2.20 | 0.15 | -2.16 | 0.17 |
